• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-酰基-4-羟基吡啶-2(1)-酮衍生物作为抗氧化剂和淀粉酶抑制剂的环境友好合成

Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1)-one derivatives as antioxidant and -amylase inhibitors.

作者信息

Yadav Neelam, Kumar Ravi, Sangwan Sarita, Dhanda Vidhi, Duhan Anil, Sindhu Jayant

机构信息

Department of Chemistry, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India.

MAP Section, Department of Genetics and Plant Breeding, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India.

出版信息

Future Med Chem. 2024 Dec;16(24):2637-2646. doi: 10.1080/17568919.2024.2432289. Epub 2024 Nov 28.

DOI:10.1080/17568919.2024.2432289
PMID:39606936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11734593/
Abstract

AIM

Oxidative stress, caused by postprandial activities, is a major global health issue causing chronic diseases like diabetes mellitus, cancer, and asthma. Therefore, it was envisaged to design and synthesize a series of substituted 4-hydroxypyridine-2(1 h)-ones in order to develop new molecules that can reduce oxidative stress and modulate α-amylase activity also.

MATERIALS & METHODS: An environmentally benign, solvent and catalyst free, natural product inspired synthesis of 4-hydroxypyridin-2(1 h)-one derivatives has been developed. The synthetic analogues were evaluated in vitro α-amylase activity and antioxidant potential.

RESULTS

Among all the synthesized compounds, , and displayed many folds higher antioxidants activity than the standard, BHT. The in vitro α-amylase inhibition was found to be moderate with IC values ranging from 5.48 to 9.31 mm as compared to the standard acarbose (IC = 0.65 mm). The most active compound against α-amylase 4c was further investigated for its binding affinity within the active site of the enzyme and the kinetics studies revealed probable uncompetitive mode of inhibition.

CONCLUSION

Compound 4a was found to be promising antioxidant and 4c as a good α-amylase inhibitor. These compounds could pave the way for development of new α-amylase inhibitors with antioxidant capabilities thereby effectively mitigating diabetes mellitus.

摘要

目的

餐后活动引起的氧化应激是一个重大的全球健康问题,会引发糖尿病、癌症和哮喘等慢性疾病。因此,设想设计并合成一系列取代的4-羟基吡啶-2(1H)-酮,以开发能够降低氧化应激并调节α-淀粉酶活性的新分子。

材料与方法

开发了一种受天然产物启发的、环境友好、无溶剂和无催化剂的4-羟基吡啶-2(1H)-酮衍生物合成方法。对合成类似物进行了体外α-淀粉酶活性和抗氧化潜力评估。

结果

在所有合成化合物中,[此处原文可能缺失具体化合物信息]显示出比标准品丁基羟基甲苯(BHT)高许多倍的抗氧化活性。与标准阿卡波糖(IC50 = 0.65 mM)相比,体外α-淀粉酶抑制作用中等,IC50值范围为5.48至9.31 mM。对α-淀粉酶活性最高的化合物4c进一步研究其在酶活性位点内的结合亲和力,动力学研究揭示了可能的非竞争性抑制模式。

结论

发现化合物4a是有前景的抗氧化剂,4c是良好的α-淀粉酶抑制剂。这些化合物可为开发具有抗氧化能力的新型α-淀粉酶抑制剂铺平道路,从而有效缓解糖尿病。

相似文献

1
Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1)-one derivatives as antioxidant and -amylase inhibitors.5-酰基-4-羟基吡啶-2(1)-酮衍生物作为抗氧化剂和淀粉酶抑制剂的环境友好合成
Future Med Chem. 2024 Dec;16(24):2637-2646. doi: 10.1080/17568919.2024.2432289. Epub 2024 Nov 28.
2
Naphthoquinone fused diazepines targeting hyperamylasemia: potential therapeutic agents for diabetes and cancer.靶向高淀粉酶血症的萘醌稠合二氮杂卓类化合物:糖尿病和癌症的潜在治疗药物。
Future Med Chem. 2024;16(21):2231-2245. doi: 10.1080/17568919.2024.2400968. Epub 2024 Sep 20.
3
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Biochemical evaluation of novel thiazolone derivatives as dual α-glucosidase/α-amylase inhibitors, anti-inflammatory agents.新型噻唑啉酮衍生物作为双功能α-葡萄糖苷酶/α-淀粉酶抑制剂及抗炎剂的生化评价
Future Med Chem. 2025 Jan;17(2):209-219. doi: 10.1080/17568919.2024.2447225. Epub 2024 Dec 29.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Synthesis of arylated tetrahydrobenzo[]quinoline-3-carbonitrile derivatives as potential hits for treatment of diabetes.芳基化四氢苯并[]喹啉-3-腈衍生物的合成作为治疗糖尿病的潜在活性化合物
Future Med Chem. 2024 Dec;16(24):2609-2625. doi: 10.1080/17568919.2024.2419359. Epub 2024 Nov 12.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Design, Synthesis, Nematicidal Evaluation, and Molecular Docking Study of Pyrano[3,2-]pyridones against .设计、合成、杀线虫活性评价及吡喃并[3,2-]吡啶酮类化合物对 的分子对接研究
J Agric Food Chem. 2024 Jul 17;72(28):15512-15522. doi: 10.1021/acs.jafc.4c00103. Epub 2024 Jul 3.
2
Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.吡喃并[2,3-c]吡唑并螺[吲哚啉]-1,2,3-三唑作为抗氧化剂:通过抑制α-淀粉酶和 DPP4 活性探索其在抗糖尿病药物开发中的应用。
Bioorg Chem. 2024 Jun;147:107363. doi: 10.1016/j.bioorg.2024.107363. Epub 2024 Apr 10.
3
Unlocking the potential of approved drugs for the allosteric inhibition of tropomyosin-receptor kinase A using molecular docking and molecular dynamics studies.
利用分子对接和分子动力学研究,挖掘已批准药物对原肌球蛋白受体激酶A变构抑制的潜力。
Front Chem. 2023 Jun 7;11:1205724. doi: 10.3389/fchem.2023.1205724. eCollection 2023.
4
Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of Their Metabolic Interconnections.高血糖与氧化应激:代谢关联的整体、更新与关键综述。
Int J Mol Sci. 2023 May 27;24(11):9352. doi: 10.3390/ijms24119352.
5
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities.合成哌啶取代查耳酮作为潜在的α-淀粉酶抑制和抗氧化活性的先导化合物。
Future Med Chem. 2023 Mar;15(6):497-515. doi: 10.4155/fmc-2022-0317. Epub 2023 Apr 24.
6
The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications.氧化应激诱导的线粒体功能障碍对糖尿病微血管并发症的影响。
Front Endocrinol (Lausanne). 2023 Feb 7;14:1112363. doi: 10.3389/fendo.2023.1112363. eCollection 2023.
7
Bioevaluation of synthetic pyridones as dual inhibitors of α-amylase and α-glucosidase enzymes and potential antioxidants.合成吡啶酮作为α-淀粉酶和α-葡萄糖苷酶的双重抑制剂及潜在抗氧化剂的生物学评价
Arch Pharm (Weinheim). 2023 Jan;356(1):e2200400. doi: 10.1002/ardp.202200400. Epub 2022 Oct 25.
8
In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2.基于药物银行实验化合物的 SARS-CoV-2 计算机筛选与分子动力学模拟
Molecules. 2022 Jul 8;27(14):4391. doi: 10.3390/molecules27144391.
9
A score years' update in the synthesis and biological evaluation of medicinally important 2-pyridones.药用重要 2-吡啶酮的合成与生物评价的多年更新。
Eur J Med Chem. 2022 Mar 15;232:114199. doi: 10.1016/j.ejmech.2022.114199. Epub 2022 Feb 15.
10
Inhibition of topoisomerase I shapes antitumor immunity through the induction of monocyte-derived dendritic cells.拓扑异构酶 I 抑制通过诱导单核细胞衍生的树突状细胞来塑造抗肿瘤免疫。
Cancer Lett. 2021 Nov 1;520:38-47. doi: 10.1016/j.canlet.2021.06.031. Epub 2021 Jul 3.